Aptose Biosciences, headquartered in North York, Ontario, specializes in developing precision anti-cancer therapies, focusing on hematology with two clinical-stage oral kinase inhibitors for hematologic malignancies. The company employs 35 staff and aims to address unmet clinical needs.